Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gitman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advances in Chronic Kidney Disease|December 12, 2018
Administrative Leadership: Nephrologists in Non-nephrology Leadership RolesMichael Gitman, Alessandro Bellucci, Steven Fishbane
Expert Opinion on Drug Safety|July 14, 2005
Immunomodulatory effect of morphine: therapeutic implicationsAmit Dinda, Michael Gitman, Pravin C Singhal
Expert Opinion on Pharmacotherapy|October 6, 2006
Emerging strategies for lowering serum phosphorous in patients with end-stage renal diseaseAkhtar Ashfaq, Michael Gitman, Pravin C Singhal
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2010
Severe hyperkalaemia resulting from octreotide use in a haemodialysis patientMadhuri Adabala, Kenar D Jhaveri, Michael Gitman
Renal Failure|January 24, 2012
Ranolazine, tacrolimus, and diltiazem might be a hazardous combination in a transplant patientHitesh Patni, Michael Gitman, Azzour Hazzan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 10, 2011
Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKDBodo B Beck, Howard Trachtman, Michael Gitman, et al.
International Journal of Environmental Research and Public Health|April 3, 2021
Effectiveness of SARS-CoV-2 Decontamination and Containment in a COVID-19 ICUZarina Brune, Cyrus E Kuschner, Joseph Mootz, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advances in Chronic Kidney Disease|December 12, 2018
Administrative Leadership: Nephrologists in Non-nephrology Leadership RolesMichael Gitman, Alessandro Bellucci, Steven Fishbane
Expert Opinion on Drug Safety|July 14, 2005
Immunomodulatory effect of morphine: therapeutic implicationsAmit Dinda, Michael Gitman, Pravin C Singhal
Expert Opinion on Pharmacotherapy|October 6, 2006
Emerging strategies for lowering serum phosphorous in patients with end-stage renal diseaseAkhtar Ashfaq, Michael Gitman, Pravin C Singhal
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2010
Severe hyperkalaemia resulting from octreotide use in a haemodialysis patientMadhuri Adabala, Kenar D Jhaveri, Michael Gitman
Renal Failure|January 24, 2012
Ranolazine, tacrolimus, and diltiazem might be a hazardous combination in a transplant patientHitesh Patni, Michael Gitman, Azzour Hazzan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 10, 2011
Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKDBodo B Beck, Howard Trachtman, Michael Gitman, et al.
International Journal of Environmental Research and Public Health|April 3, 2021
Effectiveness of SARS-CoV-2 Decontamination and Containment in a COVID-19 ICUZarina Brune, Cyrus E Kuschner, Joseph Mootz, et al.
Pageof 1